Inventor · disambiguated record
Steven Foung
Also filed as: FOUNG STEVEN · FOUNG STEVEN K · FOUNG STEVEN K H
12 granted patents·7 pending applications·528 citations·filing 1984–2025
92Inventor score
Files withUNIV LELAND STANFORD JUNIOR6FOUNG STEVEN2FOUNG STEVEN K H2GENELABS TECH INC2UNIV MARYLAND2
Top patents by PatentIndex Score
19 records- 0197US4634666AHuman-murine hybridoma fusion partnerUNIV LELAND STANFORD JUNIOR·Filed 1984·Granted Jan 6, 1987·338 cites·14 claims
- 0293US8114586B2Prevention and treatment of HCV infection employing antibodies directed against conformational and linear epitopesFOUNG STEVEN K H·Filed 2008·Granted Feb 14, 2012·68 cites·12 claims
- 0383US7879326B2Human neutralizing monoclonal antibodies to H5N1 influenza A virusUNIV LELAND STANFORD JUNIOR·Filed 2008·Granted Feb 1, 2011·9 cites·11 claims
- 0482US6692908B1Prevention and treatment of HCV infection employing antibodies that inhibit the interaction of HCV virions with their receptorUNIV STANFORD·Filed 1999·Granted Feb 17, 2004·41 cites·9 claims
- 0580US7091324B2Prevention and treatment of HCV infection employing antibodies directed against conformational epitopesUNIV LELAND STANFORD JUNIOR·Filed 2000·Granted Aug 15, 2006·14 cites·26 claims
- 0678US9732121B2Rational vaccine design for hepatitis C virusUNIV LELAND STANFORD JUNIOR·Filed 2014·Granted Aug 15, 2017·2 cites·7 claims
- 0775US6110662AHTLV-I/HTLV-II assay and methodGENELABS TECH INC·Filed 1994·Granted Aug 29, 2000·37 cites·15 claims
- 0865US10611827B2Non-human primate-derived pan-ebola and pan-filovirus monoclonal antibodies directed against envelope glycoproteinsINTEGRATED BIOTHERAPEUTICS INC·Filed 2015·Granted Apr 7, 2020·1 cites·11 claims
- 0959US2006188511A1Prevention and treatment of HCV infection employing antibodies directed against conformational and linear epitopesFOUNG STEVEN K·Filed 2004·Application pending·0 cites
- 1057US2024016923A1Modified secreted hepatitis c virus (hcv) e1e2 glycoproteins and methods of use thereofUNIV MARYLAND·Filed 2021·Application pending·0 cites
- 1153US2022054630A1Modified hepatitis c virus e2 glycoproteins and methods of use thereofUNIV MARYLAND·Filed 2021·Application pending·0 cites
- 1249US2007032635A1Prevention and treatment of HCV infection employing antibodies directed against conformational epitopesFOUNG STEVEN K H·Filed 2006·Application pending·0 cites
- 1347US4764465AHuman monoclonal antibody against group A red blood cellsCETUS CORP·Filed 1986·Granted Aug 16, 1988·12 cites·7 claims
- 1447US2025264467A1Novel hcv nucleic acids and encoded glycoprotein antigens and methodsPURDUE RESEARCH FOUNDATION·Filed 2025·Application pending·0 cites
- 1544US8858947B2Hepatitis C antibodies and uses thereofFOUNG STEVEN·Filed 2008·Granted Oct 14, 2014·0 cites·26 claims
- 1640US2003180284A1Prevention and treatment of HCV infection employing antibodies directed against conformational and linear epitopesUNIV LELAND STANFORD JUNIOR·Filed 2002·Application pending·0 cites
- 1737US4950598AProcess for making T cell hybridomasUNIV LELAND STANFORD JUNIOR·Filed 1985·Granted Aug 21, 1990·3 cites·14 claims
- 1835US2013084301A1Cluster of Neutralizing Antibodies to Hepatitis C VirusFOUNG STEVEN·Filed 2012·Application pending·0 cites
- 1933US5643714AMethod and assay for HTLVGENELABS TECH INC·Filed 1993·Granted Jul 1, 1997·3 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Steven Foung files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →